Hepatitis E virus: A zoonosis adapting to humans

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 817-821

  Bihl, Florian ^a   Negro, Francesco ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Crystal structures; Hepevirus; Liver transplantations; Vaccines

Indexed keywords

HEPATITIS E VACCINE; VIROSOME;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN STRUCTURE; VIRUS CAPSID; ZOONOSIS; ANIMAL; CLASSIFICATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; PATHOGENICITY; REVIEW; VIROLOGY; VIRUS CULTURE;

ANIMALS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MOLECULAR EPIDEMIOLOGY; VIROSOMES; VIRUS CULTIVATION; ZOONOSES;

EID: 77953706075     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq085     Document Type: Article

References (35)

1. WHO. Viral Hepatitis Statement A62/22. http://apps.who.int/gb/ebwha/pdf_files/A62/A62_22-en.pdf (22 January 2010, date last accessed).
2. Chandra V, Taneja S, Kalia M et al. Molecular biology and pathogenesis of hepatitis E virus. J Biosci 2008; 33: 451-64.
3. Das K, Agarwal A, Andrew R et al. Role of hepatitis E and other hepatotropic virus in aetiology of sporadic acute viral hepatitis: a hospital based study from urban Delhi. Eur J Epidemiol 2000; 16: 937-40.
4. Gomatos PJ, Monier MK, Arthur RR et al. Sporadic acute hepatitis caused by hepatitis E virus in Egyptian adults. Clin Infect Dis 1996; 23: 195-6.
5. Borgen K, Herremans T, Duizer E et al. Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect Dis 2008; 8: 61.
6. Renou C, Moreau X, Pariente A et al. A national survey of acute hepatitis E in France. Aliment Pharmacol Ther 2008; 27: 1086-93.
7. Dalton HR, Stableforth W, Hazeldine S et al. Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis 2008; 27: 579-85.
8. Mizuo H, Yazaki Y, Sugawara K et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005; 76: 341-9.
9. Feagins AR, Opriessnig T, Guenette DK et al. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007; 88: 912-7.
10. Yazaki Y, Mizuo H, Takahashi M et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003; 84: 2351-7.
11. Bihl F, Castelli D, Marincola F et al. Transfusion-transmitted infections. J Transl Med 2007; 5: 25.
12. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 2008; 80: 646-58.
13. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.
14. Bhatia V, Singhal A, Panda SK et al. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 1577-85.
15. Kamar N, Selves J, Mansuy JM et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-7.
16. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358: 859-60.
17. Haagsma EB, van den Berg AP, Porte RJ et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14: 547-53.
18. Le Coutre P, Meisel H, Hofmann J et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58: 699-702.
19. Herremans M, Bakker J, Duizer E et al. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007; 14: 562-8.
20. McIntosh MT, Behan SC, Mohamed FM et al. A pandemic strain of calicivirus threatens rabbit industries in the Americas. Virol J 2007; 4: 96.
21. Guo H, Zhou EM, Sun ZF et al. Protection of chickens against avian hepatitis E virus (avian HEV) infection by immunization with recombinant avian HEV capsid protein. Vaccine 2007; 25: 2892-9.
22. Chandra V, Kalia M, Hajela K et al. The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol 2010; doi:10.1128/JVI.01994-09.
23. Tanaka T, Takahashi M, Kusano E et al. Development and evaluation of an efficient cell-culture system for hepatitis E virus. J Gen Virol 2007; 88: 903-11.
24. Krawczynski K. Hepatitis E. Hepatology 1993; 17: 932-41.
25. Bradley D, Andjaparidze A, Cook EH Jr et al. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol 1988; 69: 731-8.
26. Xing L, Kato K, Li T et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T=1 particle presenting native virus epitopes. Virology 1999; 265: 35-45.
27. Guu TS, Liu Z, Ye Q et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci USA 2009; 106: 12992-7.
28. Yamashita T, Mori Y, Miyazaki N et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci USA 2009; 106: 12986-91.
29. Li S, Tang X, Seetharaman J et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLoS Pathog 2009; 5: e1000537.
30. Sallie R, Chiyende J, Tan KC et al. Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E. Gut 1994; 35: 849-53.
31. Ohnishi S, Kang JH, Maekubo H et al. A case report: two patients with fulminant hepatitis E in Hokkaido, Japan. Hepatol Res 2003; 25: 213-8.
32. Kamar N, Rostaing L, Abravanel F et al. Pegylated interferon-α for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50: e30-3.
33. Shrestha MP, Scott RM, Joshi DM et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903.
34. Zhang J, Liu CB, Li RC et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27: 1869-74.
35. Renoux VM, Fleury MJ, Bousarghin L et al. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine 2008; 26: 6602-7.